Schedule 13D ownership disclosure
ASCENDIS PHARMA A/S
Security class unavailable · CUSIP: 04351P101
Event date: 2015-05-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-15-000391
- Form type
- SC 13D
- Filer
- Adaptimmune Therapeutics PLC
- CIK
- CIK 1621227
- Filed
- May 15, 2015
- Reporting period
- May 05, 2015
- Description
- Schedule 13D beneficial ownership